首页 > 市场调查报告书 > 医疗设备

药物递输设备 DDS

市场调查报告书

商品编码

1798127

经皮给药市场，全球市场规模，2025-2029

Global Transdermal Drug Delivery Market 2025-2029

出版日期: 2025年08月14日 | 出版商:

TechNavio | 英文 228 Pages | 订单完成后即时交付

价格

简介目录图表

预计 2024 年至 2029 年间，经皮给药市场规模将达 26.66 亿美元，预测期内复合年增长率为 5.1%。

本报告对经皮给药市场进行了全面的分析，包括市场规模和预测、趋势、成长动力、挑战以及涵盖约 25 家供应商的供应商分析。

该报告提供了当前市场情景、最新趋势和驱动因素以及整体市场环境的最新分析。市场受到多种因素的驱动，例如慢性病盛行率的上升、经皮吸收贴片的使用范围的扩大以及对经皮给药的生物分解性和生物相容性材料的需求。

市场覆盖
基准年	2025
年底	2029
预测期	2025-2029
成长动力	加速度
同比	4.6%
复合年增长率	5.1%
增量金额	26.66亿美元

这项研究客观地结合了一手和二手讯息，并纳入了行业主要参与者的意见。报告包含对主要企业的分析，以及全面的市场规模数据、区域细分和供应商格局。报告包含历史数据和预测数据。

研究指出，市场对经皮药物日益增长的兴趣是未来几年推动经皮给药市场成长的关键因素之一。此外，对非侵入性治疗的强劲需求以及对业务拓展合作研究的日益重视，也将推动市场需求的大幅成长。

市场区隔
比较：按应用
止痛药：2024 年至 2029 年市场规模及预测
神经系统疾病：市场规模与预测（2024-2029）
荷尔蒙补充疗法：市场规模与预测 2024-2029
心血管疾病：2024-2029 年市场规模及预测
其他：2024-2029 年市场规模及预测
按应用分類的市场机会

第九章依类型细分市场

市场区隔
比较：按类型
经皮吸收贴片：市场规模及预测（2024-2029）
经皮半固态剂型：2024-2029 年市场规模及预测
按类型分類的市场机会

第十章按技术分類的市场细分

市场区隔
比较：按技术
微针：市场规模及预测（2024-2029）
离子电渗：市场规模及预测（2024-2029）
超音波导入：市场规模及预测（2024-2029）
电穿孔：市场规模及预测（2024-2029）
按技术分類的市场机会

第十一章客户情况

客户概览

第十二章地区情势

区域细分
区域比较
北美：市场规模及预测 2024-2029
欧洲：2024-2029 年市场规模及预测
亚洲：2024-2029 年市场规模及预测
世界其他地区：2024 年至 2029 年市场规模及预测
美国：市场规模与预测 2024-2029
加拿大：市场规模及预测（2024-2029）
德国：2024-2029年市场规模及预测
英国：市场规模及预测 2024-2029
中国：市场规模及预测（2024-2029）
墨西哥：市场规模及预测（2024-2029）
法国：2024-2029年市场规模及预测
义大利：2024-2029 年市场规模及预测
印度：市场规模及预测（2024-2029）
日本：2024-2029 年市场规模及预测
各地区市场机会

第十三章驱动因素、挑战、机会与限制因素

市场驱动因素
市场挑战
驱动因素和挑战的影响
市场机会与限制

第十四章竞争格局

概述
竞争格局
令人困惑的情况
产业风险

第十五章竞争分析

公司简介
企业排名指数
公司市场定位
Boehringer Ingelheim International GmbH
Croda International Plc
Hisamitsu Pharmaceutical Co. Inc.
Johnson and Johnson Services Inc.
Kindeva Drug Delivery LP
Luye Pharma Group Ltd.
Medherant Ltd.
Novartis AG
ProSolus Inc.
Purdue Pharma LP
Sparsha Pharma International Pvt. Ltd.
Teikoku Seiyaku Co. Ltd.
UCB SA
Viatris Inc.

第十六章附录

简介目录图表

Product Code: IRTNTR76784

The transdermal drug delivery market is forecasted to grow by USD 2,666 mn during 2024-2029, accelerating at a CAGR of 5.1% during the forecast period. The report on the transdermal drug delivery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of chronic diseases, increased applications of transdermal patches, and biodegradable and biocompatible materials for transdermal drug delivery.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	4.6%
CAGR	5.1%
Incremental Value	$2,666 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's transdermal drug delivery market is segmented as below:

By Application

Analgesics
Neurological disorders
Hormone replacement therapy
Cardiovascular disorders
Others

By Type

Transdermal patches
Transdermal semisolids

By Technology

Microneedles
Iontophoresis
Sonophoresis
Electroporation

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing interest in transdermal medicines as one of the prime reasons driving the transdermal drug delivery market growth during the next few years. Also, robust demand for non-invasive treatment and growing focus on collaborations for business expansion will lead to sizable demand in the market.

The report on the transdermal drug delivery market covers the following areas:

Transdermal Drug Delivery Market sizing
Transdermal Drug Delivery Market forecast
Transdermal Drug Delivery Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading transdermal drug delivery market vendors that include 3M Co., Boehringer Ingelheim International GmbH, Croda International PLC, Hisamitsu Pharmaceutical Co. Inc., Johnson and Johnson Services Inc., Kindeva Drug Delivery L.P., Luye Pharma Group Ltd., Medherant Ltd., Novartis AG, ProSolus Inc., Purdue Pharma LP, Rusan Pharma Ltd., Sparsha Pharma International Pvt. Ltd., Teikoku Seiyaku Co. Ltd., UCB SA, and Viatris Inc.. Also, the transdermal drug delivery market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Transdermal Drug Delivery Market 2019 - 2023
- Historic Market Size - Data Table on Global Transdermal Drug Delivery Market 2019 - 2023 ($ million)
5.2 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.3 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.4 Technology segment analysis 2019 - 2023
- Historic Market Size - Technology Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact of AI in the global transdermal drug delivery market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Application

8.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
8.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
8.3 Analgesics - Market size and forecast 2024-2029
- Chart on Analgesics - Market size and forecast 2024-2029 ($ million)
- Data Table on Analgesics - Market size and forecast 2024-2029 ($ million)
- Chart on Analgesics - Year-over-year growth 2024-2029 (%)
- Data Table on Analgesics - Year-over-year growth 2024-2029 (%)
8.4 Neurological disorders - Market size and forecast 2024-2029
- Chart on Neurological disorders - Market size and forecast 2024-2029 ($ million)
- Data Table on Neurological disorders - Market size and forecast 2024-2029 ($ million)
- Chart on Neurological disorders - Year-over-year growth 2024-2029 (%)
- Data Table on Neurological disorders - Year-over-year growth 2024-2029 (%)
8.5 Hormone replacement therapy - Market size and forecast 2024-2029
- Chart on Hormone replacement therapy - Market size and forecast 2024-2029 ($ million)
- Data Table on Hormone replacement therapy - Market size and forecast 2024-2029 ($ million)
- Chart on Hormone replacement therapy - Year-over-year growth 2024-2029 (%)
- Data Table on Hormone replacement therapy - Year-over-year growth 2024-2029 (%)
8.6 Cardiovascular disorders - Market size and forecast 2024-2029
- Chart on Cardiovascular disorders - Market size and forecast 2024-2029 ($ million)
- Data Table on Cardiovascular disorders - Market size and forecast 2024-2029 ($ million)
- Chart on Cardiovascular disorders - Year-over-year growth 2024-2029 (%)
- Data Table on Cardiovascular disorders - Year-over-year growth 2024-2029 (%)
8.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
8.8 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

9 Market Segmentation by Type

9.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
9.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
9.3 Transdermal patches - Market size and forecast 2024-2029
- Chart on Transdermal patches - Market size and forecast 2024-2029 ($ million)
- Data Table on Transdermal patches - Market size and forecast 2024-2029 ($ million)
- Chart on Transdermal patches - Year-over-year growth 2024-2029 (%)
- Data Table on Transdermal patches - Year-over-year growth 2024-2029 (%)
9.4 Transdermal semisolids - Market size and forecast 2024-2029
- Chart on Transdermal semisolids - Market size and forecast 2024-2029 ($ million)
- Data Table on Transdermal semisolids - Market size and forecast 2024-2029 ($ million)
- Chart on Transdermal semisolids - Year-over-year growth 2024-2029 (%)
- Data Table on Transdermal semisolids - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

10 Market Segmentation by Technology

10.1 Market segments
- Chart on Technology - Market share 2024-2029 (%)
- Data Table on Technology - Market share 2024-2029 (%)
10.2 Comparison by Technology
- Chart on Comparison by Technology
- Data Table on Comparison by Technology
10.3 Microneedles - Market size and forecast 2024-2029
- Chart on Microneedles - Market size and forecast 2024-2029 ($ million)
- Data Table on Microneedles - Market size and forecast 2024-2029 ($ million)
- Chart on Microneedles - Year-over-year growth 2024-2029 (%)
- Data Table on Microneedles - Year-over-year growth 2024-2029 (%)
10.4 Iontophoresis - Market size and forecast 2024-2029
- Chart on Iontophoresis - Market size and forecast 2024-2029 ($ million)
- Data Table on Iontophoresis - Market size and forecast 2024-2029 ($ million)
- Chart on Iontophoresis - Year-over-year growth 2024-2029 (%)
- Data Table on Iontophoresis - Year-over-year growth 2024-2029 (%)
10.5 Sonophoresis - Market size and forecast 2024-2029
- Chart on Sonophoresis - Market size and forecast 2024-2029 ($ million)
- Data Table on Sonophoresis - Market size and forecast 2024-2029 ($ million)
- Chart on Sonophoresis - Year-over-year growth 2024-2029 (%)
- Data Table on Sonophoresis - Year-over-year growth 2024-2029 (%)
10.6 Electroporation - Market size and forecast 2024-2029
- Chart on Electroporation - Market size and forecast 2024-2029 ($ million)
- Data Table on Electroporation - Market size and forecast 2024-2029 ($ million)
- Chart on Electroporation - Year-over-year growth 2024-2029 (%)
- Data Table on Electroporation - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by Technology
- Market opportunity by Technology ($ million)
- Data Table on Market opportunity by Technology ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.9 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.10 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.11 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.12 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
- 3M Co.
- 3M Co. - Overview
- 3M Co. - Business segments
- 3M Co. - Key news
- 3M Co. - Key offerings
- 3M Co. - Segment focus
- SWOT
15.5 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
- SWOT
15.6 Croda International Plc
- Croda International Plc - Overview
- Croda International Plc - Business segments
- Croda International Plc - Key offerings
- Croda International Plc - Segment focus
- SWOT
15.7 Hisamitsu Pharmaceutical Co. Inc.
- Hisamitsu Pharmaceutical Co. Inc. - Overview
- Hisamitsu Pharmaceutical Co. Inc. - Product / Service
- Hisamitsu Pharmaceutical Co. Inc. - Key offerings
- SWOT
15.8 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT
15.9 Kindeva Drug Delivery L.P.
- Kindeva Drug Delivery L.P. - Overview
- Kindeva Drug Delivery L.P. - Product / Service
- Kindeva Drug Delivery L.P. - Key offerings
- SWOT
15.10 Luye Pharma Group Ltd.
- Luye Pharma Group Ltd. - Overview
- Luye Pharma Group Ltd. - Business segments
- Luye Pharma Group Ltd. - Key offerings
- Luye Pharma Group Ltd. - Segment focus
- SWOT
15.11 Medherant Ltd.
- Medherant Ltd. - Overview
- Medherant Ltd. - Product / Service
- Medherant Ltd. - Key offerings
- SWOT
15.12 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
15.13 ProSolus Inc.
- ProSolus Inc. - Overview
- ProSolus Inc. - Product / Service
- ProSolus Inc. - Key offerings
- SWOT
15.14 Purdue Pharma LP
- Purdue Pharma LP - Overview
- Purdue Pharma LP - Product / Service
- Purdue Pharma LP - Key offerings
- SWOT
15.15 Sparsha Pharma International Pvt. Ltd.
- Sparsha Pharma International Pvt. Ltd. - Overview
- Sparsha Pharma International Pvt. Ltd. - Product / Service
- Sparsha Pharma International Pvt. Ltd. - Key offerings
- SWOT
15.16 Teikoku Seiyaku Co. Ltd.
- Teikoku Seiyaku Co. Ltd. - Overview
- Teikoku Seiyaku Co. Ltd. - Product / Service
- Teikoku Seiyaku Co. Ltd. - Key offerings
- SWOT
15.17 UCB SA
- UCB SA - Overview
- UCB SA - Product / Service
- UCB SA - Key offerings
- SWOT
15.18 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

简介目录图表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Market Segmentation by Technology
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global Transdermal Drug Delivery Market 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Application Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Type Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Technology Segment 2019 - 2023 ($ million)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Application - Market share 2024-2029 (%)
Exhibits39: Data Table on Application - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Application
Exhibits41: Data Table on Comparison by Application
Exhibits42: Chart on Analgesics - Market size and forecast 2024-2029 ($ million)
Exhibits43: Data Table on Analgesics - Market size and forecast 2024-2029 ($ million)
Exhibits44: Chart on Analgesics - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on Analgesics - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on Neurological disorders - Market size and forecast 2024-2029 ($ million)
Exhibits47: Data Table on Neurological disorders - Market size and forecast 2024-2029 ($ million)
Exhibits48: Chart on Neurological disorders - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on Neurological disorders - Year-over-year growth 2024-2029 (%)
Exhibits50: Chart on Hormone replacement therapy - Market size and forecast 2024-2029 ($ million)
Exhibits51: Data Table on Hormone replacement therapy - Market size and forecast 2024-2029 ($ million)
Exhibits52: Chart on Hormone replacement therapy - Year-over-year growth 2024-2029 (%)
Exhibits53: Data Table on Hormone replacement therapy - Year-over-year growth 2024-2029 (%)
Exhibits54: Chart on Cardiovascular disorders - Market size and forecast 2024-2029 ($ million)
Exhibits55: Data Table on Cardiovascular disorders - Market size and forecast 2024-2029 ($ million)
Exhibits56: Chart on Cardiovascular disorders - Year-over-year growth 2024-2029 (%)
Exhibits57: Data Table on Cardiovascular disorders - Year-over-year growth 2024-2029 (%)
Exhibits58: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits59: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits60: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits61: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits62: Market opportunity by Application ($ million)
Exhibits63: Data Table on Market opportunity by Application ($ million)
Exhibits64: Chart on Type - Market share 2024-2029 (%)
Exhibits65: Data Table on Type - Market share 2024-2029 (%)
Exhibits66: Chart on Comparison by Type
Exhibits67: Data Table on Comparison by Type
Exhibits68: Chart on Transdermal patches - Market size and forecast 2024-2029 ($ million)
Exhibits69: Data Table on Transdermal patches - Market size and forecast 2024-2029 ($ million)
Exhibits70: Chart on Transdermal patches - Year-over-year growth 2024-2029 (%)
Exhibits71: Data Table on Transdermal patches - Year-over-year growth 2024-2029 (%)
Exhibits72: Chart on Transdermal semisolids - Market size and forecast 2024-2029 ($ million)
Exhibits73: Data Table on Transdermal semisolids - Market size and forecast 2024-2029 ($ million)
Exhibits74: Chart on Transdermal semisolids - Year-over-year growth 2024-2029 (%)
Exhibits75: Data Table on Transdermal semisolids - Year-over-year growth 2024-2029 (%)
Exhibits76: Market opportunity by Type ($ million)
Exhibits77: Data Table on Market opportunity by Type ($ million)
Exhibits78: Chart on Technology - Market share 2024-2029 (%)
Exhibits79: Data Table on Technology - Market share 2024-2029 (%)
Exhibits80: Chart on Comparison by Technology
Exhibits81: Data Table on Comparison by Technology
Exhibits82: Chart on Microneedles - Market size and forecast 2024-2029 ($ million)
Exhibits83: Data Table on Microneedles - Market size and forecast 2024-2029 ($ million)
Exhibits84: Chart on Microneedles - Year-over-year growth 2024-2029 (%)
Exhibits85: Data Table on Microneedles - Year-over-year growth 2024-2029 (%)
Exhibits86: Chart on Iontophoresis - Market size and forecast 2024-2029 ($ million)
Exhibits87: Data Table on Iontophoresis - Market size and forecast 2024-2029 ($ million)
Exhibits88: Chart on Iontophoresis - Year-over-year growth 2024-2029 (%)
Exhibits89: Data Table on Iontophoresis - Year-over-year growth 2024-2029 (%)
Exhibits90: Chart on Sonophoresis - Market size and forecast 2024-2029 ($ million)
Exhibits91: Data Table on Sonophoresis - Market size and forecast 2024-2029 ($ million)
Exhibits92: Chart on Sonophoresis - Year-over-year growth 2024-2029 (%)
Exhibits93: Data Table on Sonophoresis - Year-over-year growth 2024-2029 (%)
Exhibits94: Chart on Electroporation - Market size and forecast 2024-2029 ($ million)
Exhibits95: Data Table on Electroporation - Market size and forecast 2024-2029 ($ million)
Exhibits96: Chart on Electroporation - Year-over-year growth 2024-2029 (%)
Exhibits97: Data Table on Electroporation - Year-over-year growth 2024-2029 (%)
Exhibits98: Market opportunity by Technology ($ million)
Exhibits99: Data Table on Market opportunity by Technology ($ million)
Exhibits100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits101: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits102: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits103: Chart on Geographic comparison
Exhibits104: Data Table on Geographic comparison
Exhibits105: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits138: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits139: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits142: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits143: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits146: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits147: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits149: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits150: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits151: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits152: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits153: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits154: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits155: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits156: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits157: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits158: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits159: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits160: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits161: Market opportunity By Geographical Landscape ($ million)
Exhibits162: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits163: Impact of drivers and challenges in 2024 and 2029
Exhibits164: Overview on criticality of inputs and factors of differentiation
Exhibits165: Overview on factors of disruption
Exhibits166: Impact of key risks on business
Exhibits167: Companies covered
Exhibits168: Company ranking index
Exhibits169: Matrix on companies position and classification
Exhibits170: 3M Co. - Overview
Exhibits171: 3M Co. - Business segments
Exhibits172: 3M Co. - Key news
Exhibits173: 3M Co. - Key offerings
Exhibits174: 3M Co. - Segment focus
Exhibits175: SWOT
Exhibits176: Boehringer Ingelheim International GmbH - Overview
Exhibits177: Boehringer Ingelheim International GmbH - Product / Service
Exhibits178: Boehringer Ingelheim International GmbH - Key news
Exhibits179: Boehringer Ingelheim International GmbH - Key offerings
Exhibits180: SWOT
Exhibits181: Croda International Plc - Overview
Exhibits182: Croda International Plc - Business segments
Exhibits183: Croda International Plc - Key offerings
Exhibits184: Croda International Plc - Segment focus
Exhibits185: SWOT
Exhibits186: Hisamitsu Pharmaceutical Co. Inc. - Overview
Exhibits187: Hisamitsu Pharmaceutical Co. Inc. - Product / Service
Exhibits188: Hisamitsu Pharmaceutical Co. Inc. - Key offerings
Exhibits189: SWOT
Exhibits190: Johnson and Johnson Services Inc. - Overview
Exhibits191: Johnson and Johnson Services Inc. - Business segments
Exhibits192: Johnson and Johnson Services Inc. - Key news
Exhibits193: Johnson and Johnson Services Inc. - Key offerings
Exhibits194: Johnson and Johnson Services Inc. - Segment focus
Exhibits195: SWOT
Exhibits196: Kindeva Drug Delivery L.P. - Overview
Exhibits197: Kindeva Drug Delivery L.P. - Product / Service
Exhibits198: Kindeva Drug Delivery L.P. - Key offerings
Exhibits199: SWOT
Exhibits200: Luye Pharma Group Ltd. - Overview
Exhibits201: Luye Pharma Group Ltd. - Business segments
Exhibits202: Luye Pharma Group Ltd. - Key offerings
Exhibits203: Luye Pharma Group Ltd. - Segment focus
Exhibits204: SWOT
Exhibits205: Medherant Ltd. - Overview
Exhibits206: Medherant Ltd. - Product / Service
Exhibits207: Medherant Ltd. - Key offerings
Exhibits208: SWOT
Exhibits209: Novartis AG - Overview
Exhibits210: Novartis AG - Business segments
Exhibits211: Novartis AG - Key news
Exhibits212: Novartis AG - Key offerings
Exhibits213: Novartis AG - Segment focus
Exhibits214: SWOT
Exhibits215: ProSolus Inc. - Overview
Exhibits216: ProSolus Inc. - Product / Service
Exhibits217: ProSolus Inc. - Key offerings
Exhibits218: SWOT
Exhibits219: Purdue Pharma LP - Overview
Exhibits220: Purdue Pharma LP - Product / Service
Exhibits221: Purdue Pharma LP - Key offerings
Exhibits222: SWOT
Exhibits223: Sparsha Pharma International Pvt. Ltd. - Overview
Exhibits224: Sparsha Pharma International Pvt. Ltd. - Product / Service
Exhibits225: Sparsha Pharma International Pvt. Ltd. - Key offerings
Exhibits226: SWOT
Exhibits227: Teikoku Seiyaku Co. Ltd. - Overview
Exhibits228: Teikoku Seiyaku Co. Ltd. - Product / Service
Exhibits229: Teikoku Seiyaku Co. Ltd. - Key offerings
Exhibits230: SWOT
Exhibits231: UCB SA - Overview
Exhibits232: UCB SA - Product / Service
Exhibits233: UCB SA - Key offerings
Exhibits234: SWOT
Exhibits235: Viatris Inc. - Overview
Exhibits236: Viatris Inc. - Business segments
Exhibits237: Viatris Inc. - Key news
Exhibits238: Viatris Inc. - Key offerings
Exhibits239: Viatris Inc. - Segment focus
Exhibits240: SWOT
Exhibits241: Inclusions checklist
Exhibits242: Exclusions checklist
Exhibits243: Currency conversion rates for US$
Exhibits244: Research methodology
Exhibits245: Information sources
Exhibits246: Data validation
Exhibits247: Validation techniques employed for market sizing
Exhibits248: Data synthesis
Exhibits249: 360 degree market analysis
Exhibits250: List of abbreviations

02-2729-4219

+886-2-2729-4219

License/价格

经皮给药市场，全球市场规模，2025-2029

Global Transdermal Drug Delivery Market 2025-2029

目录

第一章执行摘要

第二章 Technavio 分析

第三章市场状况

第四章市场规模

第五章市场规模表现

第六章定性分析

第七章五力分析

第 8 章按应用分類的市场区隔